enVVeno Share Price
NASDAQ: NVNO | HealthcareenVVeno Stock Performance
enVVeno Share Price Chart
enVVeno Quarterly Profit & Loss
All figures in USD
enVVeno Annual Profit & Loss
All figures in USD
enVVeno Balance Sheet
All figures in USD Million
enVVeno Cash Flow
All figures in USD Million
Corporate Actions
About enVVeno
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
enVVeno Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $6.89 | $5.70 | -15.56% |
Oct 2026 | $8.04 | $6.75 | -20.12% |
Sep 2026 | $11.01 | $8.45 | -19.91% |
Aug 2026 | $11.02 | $10.55 | +0.38% |
Jul 2026 | $11.58 | $10.51 | -4.45% |
Jun 2026 | $11.06 | $11.00 | -0.59% |
May 2026 | $10.94 | $11.06 | -2.08% |
Apr 2026 | $10.38 | $11.30 | +6.00% |
Mar 2026 | $10.79 | $10.66 | -5.50% |
Feb 2026 | $12.13 | $11.28 | +18.12% |
Jan 2026 | $0.33 | $9.55 | +2,922.15% |
Dec 2025 | $0.38 | $0.32 | -17.71% |